Mathew Martoma is an American former hedge fund trader. As a portfolio manager at S.A.C. ... to sell shares of pharmaceutical companies Wyeth and Elan Corporation based on tips from two doctors, including Sid Gilman of the University of Michigan, about the Alzheimer's disease drug bapineuzumab during clinical trials ...


Wyeth v. Levine (2009) established that such claims may go forward—in other words, they are ...... Strayhorn panel, Judge Gillman observed that the court felt.


Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 12e ...... of the U.S. added further fuel to these fiery issues in 2009 in the case Wyeth v.


View Steve Gilman's profile on LinkedIn, the world's largest professional community. Steve has ... Scientist, Inflammation Research. Wyeth. 1981 – 1987 6 years ...


I was privileged to work with Betsy for 11 years, both as Wyeth and Pfizer colleagues. Betsy is a strategic thinker, always looking for opportunity to improve  ...


He has served as a consultant for Wyeth, ReNeuron, Adamas, and Kyowa and has grant support from ... Address correspondence and reprint requests to Dr. Sid Gilman, Department of Neurology, ... Colosimo C, Vanacore N, Bonifati V, et al.


Oct 13, 2014 ... But in recent years two pharmaceutical companies, Elan and Wyeth, had worked ... By the time Gilman made his presentation, however, S.A.C. Capital no longer owned ...... Martoma was there, wearing a neat V-neck sweater.


Smith v. Wyeth, Inc., 657 F.3d 420 (6th Cir. Sept. 22, 2011) (metoclopramide). State law ...... Gillman v. Boston Scientific Corp., 2012 WL 892239 (Mag. D. Or. Jan.


Aug 25, 2017 ... In December 2014, the Second Circuit in United States v. ... made public, Elan and Wyeth stock plummeted, and the trades made in advance of ... Specifically, Martoma argued that Dr. Gilman was only a casual acquaintance ...